Resistant hypertension: incidence, prevalence, and prognosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation

• Publication date

  2012-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.112.097345PMID 22379111PMCID PMC3350774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abstract 248: National Trends in Utilization and Economic Outcomes of Catheter Ablation for Atrial Fibrillation in the United States 2003-2008

  2014cited by this paper
• Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

  2013influential reference
• Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

  2012cited by this paper
• Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

  2012cited by this paper
• What is the prevalence of resistant hypertension in the United States?

  2012cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2012cited by this paper
• Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk

  2011cited by this paper
• Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

  2011cited by this paper
• Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

  2011cited by this paper
• Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

  2011cited by this paper
• Prevalence of Resistant Hypertension in the United States, 2003–2008

  2011cited by this paper
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

  2011cited by this paper
• Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial

  2009cited by this paper
• Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone

  2009cited by this paper
• Relation of Dietary Salt and Aldosterone to Urinary Protein Excretion in Subjects With Resistant Hypertension

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• ORIGINAL PAPERS

  2007cited by this paper
• Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

  2004cited by this paper
• Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

  2002cited by this paper
• Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2002cited by this paper
• OR-46: High prevalence of primary aldosteronism among black and white subjects with resistant hypertension

  2002cited by this paper
• Original Papers

  1986cited by this paper

• Aqueous leaf extract of Vitex negundo modulates M1-M2 phenotypic switch and functional changes in human macrophages in an in vitro model of hypertension

  2025cites this paper
• Renal Artery Stent Procedural Trends and Disparities in a National Cohort.

  2025cites this paper
• Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24

  2025cites this paper
• Forgotten Circulation: Reduced Mesenteric Venous Capacitance in Hypertensive Rats Is Improved by Decreasing Sympathetic Activity

  2024cites this paper
• Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage

  2024cites this paper
• Comparing the Efficacy of Renal Artery Denervation in Uncontrolled Hypertension: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Screening of serum markers in patients with resistant hypertension

  2024cites this paper
• Advanced echocardiography techniques (AETs) to assess left atrial structure and function in individuals with resistant hypertension

  2023cites this paper
• The many faces of hypertension in individuals with type 1 diabetes.

  2023cites this paper
• Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC

  2023cites this paper
• The association of anthropometric indices and resistant hypertension among type 2 diabetes: a case study of patients attending Kisii Teaching and Referral Hospital, Kenya

  2023cites this paper
• Prevalence of resistant hypertension and its relation with plasma lipoprotein-associated phospholipase A2

  2023cites this paper
• A Deployable Multifunctional Sensor for a Catheter Device for the Renal Denervation of Resistant Hypertension

  2023influential citation
• Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Real-World Observation Study

  2023cites this paper
• Application of myocardial work in predicting adverse events among patients with resistant hypertension

  2023cites this paper
• Novel Dual Endothelin Inhibitors in the Management of Resistant Hypertension

  2023cites this paper
• Predicting Renal Denervation Response in Resistant High Blood Pressure by Arterial Stiffness Assessment: A Systematic Review

  2022cites this paper
• Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension

  2022cites this paper
• Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship

  2022cites this paper
• Renal denervation in resistant hypertension: a review of clinical trials and future perspectives

  2022cites this paper
• Clinical Effect of Renal Arterial Sympathetic Radiofrequency Ablation on Secondary Hypertension

  2022cites this paper
• Renal sympathetic denervation in resistant hypertension: The association between vitamin D and positive early response in systolic blood pressure.

  2022cites this paper
• Hipertensão pseudorresistente causada por inadequação do regime terapêutico

  2022cites this paper
• Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test

  2022cites this paper
• The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19

  2021cites this paper
• Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease

  2021cites this paper
• Catheter Based Renal Sympathetic Denervation by Segmental Endoluminal Laser Radiation in a Pig Model: Anatomical and Histopathological Results

  2021cites this paper
• Angio-computed tomography reveals differences in the anatomy of renal arteries in resistant hypertension patients qualified for renal denervation versus pseudo-resistant hypertensive subjects

  2021cites this paper
• Identification and management of resistant hypertension

  2021cites this paper
• Renal Denervation and Celiac Ganglionectomy Decrease Mean Arterial Pressure Similarly in Genetically Hypertensive Schlager (BPH/2J) Mice

  2021cites this paper
• The δ subunit of Epithelial sodium channel in humans - a potential player in vascular physiology.

  2020cites this paper
• Quantitative analysis of renal arterial variations affecting the eligibility of catheter-based renal denervation using multi-detector computed tomography angiography

  2020cites this paper
• Development and validation of a UPLC-DAD method for the simultaneous quantification of eight antihypertensive drugs in the pharmaceutical matrix.

  2020cites this paper
• Treatment of resistant hypertension.

  2020cites this paper
• Contemporary Strategies to Manage High Blood Pressure in Patients with Coexistent Resistant Hypertension and Heart Failure With Reduced Ejection Fraction

  2020cites this paper
• Resistant Hypertension in a Dialysis Patient.

  2020cites this paper
• A qualitative comparison of high and low adherers with apparent treatment-resistant hypertension

  2020influential citation
• Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study

  2020cites this paper
• Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment

  2020cites this paper
• Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension

  2020cites this paper
• Hypertensive Crisis in Pediatric Patients: An Overview

  2020cites this paper
• Therapeutic effect and prognostic life quality of renal denervation therapy and nifedipine combined with metoprolol tartrate in the treatment of resistant hypertension

  2019cites this paper
• Role of Physical Activity, Exercise, and Cardiorespiratory Fitness in the Management of Resistant Hypertension

  2019cites this paper
• Renal revascularization in resistant hypertension.

  2019cites this paper
• Renal denervation: Alternative treatment options for hypertension?

  2019cites this paper
• Resistant Hypertension.

  2019cites this paper
• How Does Preexisting Hypertension Affect Patients with Intracerebral Hemorrhage?

  2019cites this paper
• When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?

  2019cites this paper
• Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study

  2019cites this paper
• SÍNDROME DO JALECO BRANCO E FATORES DE RISCO ASSOCIADOS A HIPERTENSÃO ARTERIAL CONTROLADA (HAC), RESISTENTE (HAR) E PSEUDORRESISTENTE (HAPR) EM IDOSOS INSTITUCIONALIZADOS

  2019cites this paper
• Renal Denervation : A Mathematical Analysis of Technology and the Treatment of Resistant Hypertension

  2019cites this paper
• Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions

  2019cites this paper
• Resistant Hypertension: Questions and Contemporary Answers

  2019cites this paper
• Renal Sympathetic Denervation

  2019cites this paper
• Improving blood pressure control in patients with pseudoresistant hypertension A pilot randomized trial

  2019cites this paper
• Arterial Destiffening Starts Early after Renal Artery Denervation

  2019cites this paper
• NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension

  2019cites this paper
• Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

  2019cites this paper
• Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study

  2019cites this paper
• Prognosis of patients with apparent treatment-resistant hypertension—a feasibility study

  2018cites this paper
• Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure

  2018cites this paper
• Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence

  2018cites this paper
• Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case−control study

  2018cites this paper
• Pharmacological potentiation of the efferent vagus nerve attenuates blood pressure and renal injury in a murine model of systemic lupus erythematosus.

  2018cites this paper
• Medication adherence in resistant hypertension: An investigation of prevalence, psychological predictors and patient perspectives

  2018cites this paper
• Severe Renal Artery Stenosis

  2018cites this paper
• Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

  2018cites this paper
• Effects of renal sympathetic denervation on myocardial structure, function and perfusion: A serial CMR study.

  2018cites this paper
• Resistant Hypertension 2018

  2018cites this paper
• Drug utilization, adherence and occurrence of Resistant Hypertension among hypertensive patients visiting community based screening and management program in Eastern Nepal

  2018cites this paper
• Development of Three Dimensional Roll-up Polymer-Si Structure for Nerve Ablation Catheter

  2018cites this paper
• Alterações agudas na pressão arterial e parâmetros hemodinâmicos após exercícios aeróbico, de resistência e combinado em hipertensos resistentes : Acute alterations in blood pressure and hemodynamic parameters after aerobic, resistance and combined exercises in resistant hypertension

  2018cites this paper
• A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples.

  2018cites this paper
• Public Health Efforts for Earlier Resistant Hypertension Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Better Adherence, and Reimbursement Policies

  2017cites this paper
• Renal Artery Stenosis: When to Revascularize in 2017.

  2017cites this paper
• Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension

  2017cites this paper
• Management of Hypertension in Primary Care Safety‐Net Clinics in the United States: A Comparison of Community Health Centers and Private Physicians' Offices

  2017cites this paper
• The prevalence of resistant arterial hypertension and secondary causes in a cohort of hypertensive patients: a single center experience

  2017cites this paper
• Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015

  2017cites this paper
• Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial

  2017cites this paper
• The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease

  2017cites this paper
• Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm?

  2017cites this paper
• ОТБОР БОЛЬНЫХ РЕЗИСТЕНТНОЙ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ ДЛЯ ВЫПОЛНЕНИЯ РЕНАЛЬНОЙ ДЕНЕРВАЦИИ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

  2017cites this paper
• Resistant Hypertension in Chronic Kidney Disease

  2017cites this paper
• Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation

  2017cites this paper
• Resistant Hypertension.

  2017cites this paper
• Renal Denervation to Modify Hypertension and the Heart Failure State.

  2017cites this paper
• UHPLC–MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples

  2017cites this paper
• Obstructive sleep apnea syndrome and sleep quality in hypertensive patients.

  2017cites this paper
• Nonadherence to antihypertensive medications in adults with high risk for obstructive sleep apnea

  2017cites this paper
• Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47phox and iNOS in nitric oxide deficient rats.

  2017cites this paper
• Coronary flow reserve in patients with resistant hypertension

  2017cites this paper
• Effect of catheter-based renal denervation on left ventricular function, mass and (un)twist with two-dimensional speckle tracking echocardiography

  2017cites this paper
• КЛІНІКО-ФУНКЦІОНАЛЬНА ХАРАКТЕРИСТИКА РЕЗИСТЕНТНОСТІ АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇ

  2017cites this paper
• Hypertension and obstructive sleep apnea

  2016cites this paper
• Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial

  2016cites this paper
• Angiotensin-Converting Enzyme Inhibitor-Induced Cough Prevalence in Refractory Hypertensive Patients

  2016cites this paper
• Update in Hypertension Therapy.

  2016cites this paper
• Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.

  2016cites this paper
• Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)

  2016cites this paper